- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Classical Phenylketonuria(PKU) in New Zealand
Total 60 results
-
BioMarin PharmaceuticalRecruitingPhenylketonuria (PKU)United States
-
BioMarin PharmaceuticalActive, not recruiting
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States
-
BioMarin PharmaceuticalRecruitingPhenylketonuria (PKU)United States, Germany, Italy
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingClassical Hodgkin Lymphoma | Lymphocyte-Depleted Classical Hodgkin Lymphoma | Lymphocyte-Rich Classical Hodgkin Lymphoma | Mixed Cellularity Classical Hodgkin Lymphoma | Nodular Sclerosis Classical Hodgkin LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingLymphocyte-Rich Classical Hodgkin Lymphoma | Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma | Recurrent Mixed Cellularity Classical Hodgkin Lymphoma | Recurrent Nodular Sclerosis Classical Hodgkin Lymphoma | Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma | Refractory Mixed... and other conditionsUnited States
-
Homology Medicines, IncEnrolling by invitationPhenylketonuria | PAH DeficiencyUnited States
-
BioMarin PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedPhenylketonuriasUnited States
-
BioMarin PharmaceuticalCompletedPhenylketonuriasUnited States
-
Tulane University School of MedicineBioMarin PharmaceuticalCompletedPhenylketonuria | Behavior and Behavior Mechanisms | PAH Gene ExpressionUnited States
-
BioMarin PharmaceuticalCompletedStudy of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006PhenylketonuriaUnited States
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
BioMarin PharmaceuticalApproved for marketing
-
BioMarin PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
SynlogicCompletedPhenylketonuriaUnited States
-
BioMarin PharmaceuticalCompletedPhenylketonuria | HyperphenylalaninaemiaUnited States
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
BioMarin PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
Homology Medicines, IncTerminated
-
Jnana TherapeuticsRecruitingPhenylketonuriaUnited States, Australia
-
PTC TherapeuticsRecruitingPhenylketonuriaUnited States, Germany, Spain, Australia, Brazil, United Kingdom, Denmark, Mexico, Portugal, Turkey, Canada, Georgia, Italy, Netherlands, Japan
-
PTC TherapeuticsCompletedPhenylketonuriaSpain, United States, Australia, Germany, United Kingdom, Brazil, Denmark, Canada, France, Georgia, Italy, Mexico, Netherlands, Portugal, Turkey
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States, Canada
-
BioMarin PharmaceuticalCompletedTetrahydrobiopterin Deficiencies | Hyperphenylalaninemia, Non-PhenylketonuricGermany, United States
-
University of GiessenDeutsche Krebshilfe e.V., Bonn (Germany); Euronet WorldwideActive, not recruitingClassical Hodgkin LymphomaUnited Kingdom, Australia, Austria, Belgium, Czechia, Denmark, France, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Spain, Sweden, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedStage III Childhood Hodgkin Lymphoma | Stage IV Childhood Hodgkin Lymphoma | Stage I Childhood Hodgkin Lymphoma | Stage II Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma | Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma | Childhood Mixed Cellularity... and other conditionsUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland, Israel
-
University of VirginiaMerck Sharp & Dohme LLCRecruitingClassical Hodgkin LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingClassic Hodgkin Lymphoma | Lymphocyte-Rich Classic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann Arbor Stage II Hodgkin Lymphoma | Ann Arbor Stage IIA Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Ann Arbor Stage I Hodgkin Lymphoma | Ann Arbor Stage I Mixed Cellularity... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedClassical Hodgkin's LymphomaSpain, France, Belgium, Italy, Israel, Germany, United States, Australia, Brazil, Singapore, Malaysia, New Zealand, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma | Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma | Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Ann Arbor Stage IV... and other conditionsUnited States, Canada, Puerto Rico
-
BeiGeneLymphoma Study AssociationActive, not recruitingClassical Hodgkin LymphomaUnited States, Australia, France, Belgium, Puerto Rico
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory Classical Hodgkin LymphomaItaly, United States, United Kingdom, Canada, Spain, France, Denmark
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); University of California, San Francisco; George... and other collaboratorsCompletedCancer | Non-Hodgkin's Lymphoma | AIDS | Kaposi's Sarcoma AIDS Related | Kaposi's Sarcoma Classical | HEMATOPOIETIC SYSTEMUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingClassical Hodgkin LymphomaPoland, United States, Australia, Canada, Chile, France, Israel, Italy, Russian Federation, Spain, Turkey
-
Montefiore Medical CenterSuspendedMigraine Disorders | Migraine Without Aura | Migraine, ClassicUnited States
-
Yale UniversityWithdrawnHematopoietic/Lymphoid Cancer | Infectious Mononucleosis | PTLD | Lymphoid Tumor | Plasmacytic Hyperplasia PTLD | Florid Follicular Hyperplasia PTLD | Polymorphic PTLD | Monomorphic PTLD | Classical Hodgkin Lymphoma Type PTLDUnited States
-
National Cancer Institute (NCI)SuspendedRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Classic Hodgkin LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRelapsed Classic Hodgkin LymphomaUnited States
-
Applied Therapeutics, Inc.Active, not recruiting
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedClassic Hodgkin Lymphoma | Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 | Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8United States
-
National Cancer Institute (NCI)RecruitingHIV Infection | Advanced Malignant Solid Neoplasm | Kaposi Sarcoma | Lung Carcinoma | Metastatic Malignant Solid Neoplasm | Unresectable Solid Neoplasm | Anal Carcinoma | Recurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States, Australia
-
GenmabAbbVieRecruitingDiffuse Large B-Cell Lymphoma | Classic Follicular LymphomaUnited States, Puerto Rico
-
Merck Sharp & Dohme LLCRecruitingMelanoma | Lymphoma | Solid Tumor | Classical Hodgkin Lymphoma | Microsatellite-instability-high Solid TumorFrance, Germany, Italy, Netherlands, Sweden, United Kingdom, Brazil, Israel, Korea, Republic of, United States